266 related articles for article (PubMed ID: 26042469)
21. CYP-mediated drug metabolism in the brain impacts drug response.
McMillan DM; Tyndale RF
Pharmacol Ther; 2018 Apr; 184():189-200. PubMed ID: 29024742
[TBL] [Abstract][Full Text] [Related]
22. Interactions between CYP3A4 and Dietary Polyphenols.
Basheer L; Kerem Z
Oxid Med Cell Longev; 2015; 2015():854015. PubMed ID: 26180597
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
[TBL] [Abstract][Full Text] [Related]
24. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
25. Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling.
Cipolletti M; Solar Fernandez V; Montalesi E; Marino M; Fiocchetti M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30189583
[TBL] [Abstract][Full Text] [Related]
26. Polyphenols, their Metabolites and Derivatives as Drug Leads.
Almeida AF; Dos Santos CN; Ventura MR
Curr Pharm Des; 2018; 24(19):2188-2207. PubMed ID: 29766784
[TBL] [Abstract][Full Text] [Related]
27. Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humans.
Baer-Dubowska W; Szaefer H
Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):927-41. PubMed ID: 23634851
[TBL] [Abstract][Full Text] [Related]
28. NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms.
Zhu BT; Lee AJ
Steroids; 2005 Apr; 70(4):225-44. PubMed ID: 15784278
[TBL] [Abstract][Full Text] [Related]
29. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
[TBL] [Abstract][Full Text] [Related]
30. Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism.
Bishop-Bailey D; Thomson S; Askari A; Faulkner A; Wheeler-Jones C
Annu Rev Nutr; 2014; 34():261-79. PubMed ID: 24819323
[TBL] [Abstract][Full Text] [Related]
31. Enzyme kinetics of oxidative metabolism: cytochromes P450.
Korzekwa K
Methods Mol Biol; 2014; 1113():149-66. PubMed ID: 24523112
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors.
Schneider E; Clark DS
Biosens Bioelectron; 2013 Jan; 39(1):1-13. PubMed ID: 22809523
[TBL] [Abstract][Full Text] [Related]
33. Prediction of cytochrome P450 mediated metabolism.
Olsen L; Oostenbrink C; Jørgensen FS
Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
[TBL] [Abstract][Full Text] [Related]
34. The Role of Cytochromes P450 in Infection.
Stavropoulou E; Pircalabioru GG; Bezirtzoglou E
Front Immunol; 2018; 9():89. PubMed ID: 29445375
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 and myocardial ischemia: potential pharmacological implication for cardioprotection.
Barau C; Ghaleh B; Berdeaux A; Morin D
Fundam Clin Pharmacol; 2015 Feb; 29(1):1-9. PubMed ID: 24990103
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression.
Genovese S; Epifano F; Curini M; Menger D; Zembruski NC; Weiss J
Phytomedicine; 2011 May; 18(7):586-91. PubMed ID: 21112752
[TBL] [Abstract][Full Text] [Related]
37. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications.
Zhang YY; Yang L
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):621-9. PubMed ID: 19473111
[TBL] [Abstract][Full Text] [Related]
38. Implications of Resveratrol on Glucose Uptake and Metabolism.
León D; Uribe E; Zambrano A; Salas M
Molecules; 2017 Mar; 22(3):. PubMed ID: 28272357
[TBL] [Abstract][Full Text] [Related]
39. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
40. Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.
Ciolino HP; MacDonald CJ; Memon OS; Bass SE; Yeh GC
Carcinogenesis; 2006 Aug; 27(8):1586-92. PubMed ID: 16531450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
